Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 4
1950 1
1953 1
1954 1
1956 1
1957 3
1958 2
1959 1
1962 1
1967 1
1969 1
1970 1
1971 3
1972 2
1975 1
1977 1
1979 1
1981 2
1982 1
1985 1
1986 1
1988 2
1990 1
1994 1
1996 1
1999 1
2001 2
2002 2
2003 3
2004 3
2005 8
2006 1
2008 1
2009 2
2010 1
2011 1
2012 1
2013 5
2014 2
2015 3
2016 1
2017 1
2018 4
2019 3
2020 5
2021 7
2022 8
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
Jabbour SK, Lee KH, Frost N, Breder V, Kowalski DM, Pollock T, Levchenko E, Reguart N, Martinez-Marti A, Houghton B, Paoli JB, Safina S, Park K, Komiya T, Sanford A, Boolell V, Liu H, Samkari A, Keller SM, Reck M. Jabbour SK, et al. Among authors: houghton b. JAMA Oncol. 2021 Jun 4;7(9):1-9. doi: 10.1001/jamaoncol.2021.2301. Online ahead of print. JAMA Oncol. 2021. PMID: 34086039 Free PMC article.
Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
Borghaei H, Langer CJ, Paz-Ares L, Rodríguez-Abreu D, Halmos B, Garassino MC, Houghton B, Kurata T, Cheng Y, Lin J, Pietanza MC, Piperdi B, Gadgeel SM. Borghaei H, et al. Among authors: houghton b. Cancer. 2020 Nov 15;126(22):4867-4877. doi: 10.1002/cncr.33142. Epub 2020 Sep 11. Cancer. 2020. PMID: 32914866 Free PMC article.
Gene Therapy for Primary Immunodeficiency.
Houghton BC, Booth C. Houghton BC, et al. Hemasphere. 2020 Dec 29;5(1):e509. doi: 10.1097/HS9.0000000000000509. eCollection 2021 Jan. Hemasphere. 2020. PMID: 33403354 Free PMC article. Review.
Therapeutic gene editing of T cells to correct CTLA-4 insufficiency.
Fox TA, Houghton BC, Petersone L, Waters E, Edner NM, McKenna A, Preham O, Hinze C, Williams C, de Albuquerque AS, Kennedy A, Pesenacker AM, Genovese P, Walker LSK, Burns SO, Sansom DM, Booth C, Morris EC. Fox TA, et al. Among authors: houghton bc. Sci Transl Med. 2022 Oct 26;14(668):eabn5811. doi: 10.1126/scitranslmed.abn5811. Epub 2022 Oct 26. Sci Transl Med. 2022. PMID: 36288278
Gene Edited T Cell Therapies for Inborn Errors of Immunity.
Fox TA, Houghton BC, Booth C. Fox TA, et al. Among authors: houghton bc. Front Genome Ed. 2022 Jun 16;4:899294. doi: 10.3389/fgeed.2022.899294. eCollection 2022. Front Genome Ed. 2022. PMID: 35783679 Free PMC article. Review.
Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
Topal J, Panchal N, Barroeta A, Roppelt A, Mudde A, Gaspar HB, Thrasher AJ, Houghton BC, Booth C. Topal J, et al. Among authors: houghton bc. J Clin Immunol. 2023 Feb;43(2):440-451. doi: 10.1007/s10875-022-01389-0. Epub 2022 Nov 3. J Clin Immunol. 2023. PMID: 36329240 Free PMC article.
99 results